Sai Life Sciences Limited (SAILIFE)
Press Release for the Unaudited financial results for the quarter ended 30 June 2026
Press Release - Q1FY27
- Revenue 554cr +12% y-y; EBITDA 148cr +18% y-y (margin 27%, +200 bps); PAT 73cr +22% y-y
- CRO business grew 24% y-y; CDMO pipeline strong with 33 commercial and 14 late-phase molecules
- New 100,000 sq. ft. R&D facility operational at Genome Valley, Hyderabad
- EcoVadis Platinum Rating achieved, top 1% globally for sustainability
- CFO: healthy balance sheet and disciplined capital allocation support long-term growth
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 SAILIFE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add SAILIFE to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Sai Life Sciences Limited
Important.
The summary above is generated automatically from Sai Life Sciences Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.